Benefits of a 6-month, Individualized, Hybrid, "Real-life" Adapted Physical Activity Program on the Quality of Life of Patients Treated for Multiple Myeloma
No applicable phase (e.g. observational)
Conditions:
Multiple Myeloma (MM)
Sponsor: Centre Hospitalier Metropole Savoie
trial.available_in:
БГ
Overview
The goal of this clinical trial is to evaluate the effect of a long-term, individualized, hybrid adapted physical activity program on the quality of life of patients with multiple myeloma. The main question it aims to answer are :
Does this logn term, individualized and hybrid adapted physical activity program improve quality of life in multiple myeloma patient ? What are the effects of this program on effort tolerance, pain, muscular mass, osteolytic lesions, tolerance to treatment, response to treatment? If there is a comparison group: Researchers will compare \[arm information\] to see if \[insert effects\].
Participants will be randomised in 2 groups.
* control group: patients will receive only advices about physical activities benefit
* interventional group: This group will be offered a program of adapted physical activities mixing sessions at home (remote) and sessions at the hospital (in person).
Who can participate
Inclusion Criteria:
* newly diagnosed or relapse multiple myeloma, \> 60 yo, not eligible to transplant
* 1st to 4th line of treatment initiated during the last 3 months
* receiving a systemic treatment that involved visit to the hospital at least twice a month durig the first 3 months and at least once a month the next 3 months
Exclusion Criteria:
* severe cardiac amyloidosis
* absolute contraindication to physical activity
* inability to comply with the protocol requirements
* not french speaker
* patient under guardianship or curatorship
* pregnant or lactating women